Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology IV1 Apr 2017MP99-11 ANGIOMOTIN REGULATES PROSTATE CANCER CELL PROLIFERATION BY SIGNALING THROUGH HIPPO-YAP PATHWAY Pengfei Shen, Hao Zeng, Angelica Ortiz, Chien-Jui Cheng, Yu-Chen Lee, Guoyu Yu, Song-Chang Lin, Li-Yuan Yu-Lee, and Sue-Hwa Lin Pengfei ShenPengfei Shen More articles by this author , Hao ZengHao Zeng More articles by this author , Angelica OrtizAngelica Ortiz More articles by this author , Chien-Jui ChengChien-Jui Cheng More articles by this author , Yu-Chen LeeYu-Chen Lee More articles by this author , Guoyu YuGuoyu Yu More articles by this author , Song-Chang LinSong-Chang Lin More articles by this author , Li-Yuan Yu-LeeLi-Yuan Yu-Lee More articles by this author , and Sue-Hwa LinSue-Hwa Lin More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.3097AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Angiomotin (AMOT) is a family of proteins found to be a component of the apical junctional complex of vertebrate epithelial cells and is recently found to play important roles in neurofibromatosis type 2 (NF-2). Whether AMOT plays a role in prostate cancer (PCa) is unknown. METHODS Purified GST-AMOTp80 was used as immunogen for antibody generation. Real-time PCR, western blot and immunohistochemistry were used to identify the expression of AMOT. To study the function of AMOT, retroviral vector were constructed, also shRNA was used to knockdown AMOT in cells. Cell migration and invasion assays were performed by using transwell chambers. Nuclear and cytoplasmic protein fractions were prepared by using NE-PER reagents (Pierce). The SPSS 19.0 software was used for statistical analysis. Chi-square test and t test were used for the comparisons between groups. RESULTS AMOT is expressed as two isoforms, AMOTp80 and AMOTp130, which has a 409 aa N-terminal domain that is absent in AMOTp80. Both AMOTp80 and AMOTp130 are expressed in LNCaP and C4-2B4, but at a low to undetectable level in PC3 cells. Further study showed that AMOTp130 and AMOTp80 have distinct functions in PCa cells. We found that AMOTp80 functioned as a tumor promoter by enhancing PCa cell proliferation while AMOTp130 did not. Mechanistic studies showed that AMOTp80 signaled through the Hippo pathway by promoting the nuclear translocation of YAP, resulting in an increased expression of YAP target protein BMP4. Moreover, inhibition of BMP receptor activity by LDN-193189 abrogates AMOTp80-mediated cell proliferation. CONCLUSIONS Together, this study reveals a novel mechanism whereby the AMOTp80-Merlin-MST1-LATS-YAP-BMP4 pathway leads to AMOTp80-induced tumor cell proliferation. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e1324 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Pengfei Shen More articles by this author Hao Zeng More articles by this author Angelica Ortiz More articles by this author Chien-Jui Cheng More articles by this author Yu-Chen Lee More articles by this author Guoyu Yu More articles by this author Song-Chang Lin More articles by this author Li-Yuan Yu-Lee More articles by this author Sue-Hwa Lin More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

AmotP130 regulates Rho GTPase and decreases breast cancer cell mobility.

Angiomotin-p130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancer

Angiomotin promotes breast cancer cell proliferation and invasion.

Modulation of tumor cell migration, invasion and cell-matrix adhesion by human monopolar spindle-one-binder 2.

Angiomotin Family Members: Oncogenes Or Tumor Suppressors?

Phosphorylation of Angiomotin by Lats1/2 Kinases Inhibits F-actin Binding, Cell Migration, and Angiogenesis

Angiomotin-p130 Inhibits Vasculogenic Mimicry Formation of Small Cell Lung Cancer Independently of Smad2/3 Signal Pathway

The Physiological Role of Motin Family and Its Dysregulation in Tumorigenesis

ANGPTL1 Attenuates Colorectal Cancer Metastasis by Up-Regulating Microrna-138

Angiomotin is a Novel Hippo Pathway Component That Inhibits YAP Oncoprotein.

AMOTL2‑knockdown Promotes the Proliferation, Migration and Invasion of Glioma by Regulating Β‑catenin Nuclear Localization.

Proteomic Identification Of Angiomotin By Proteomelab Pf-2d And Correlation With Clinical Outcome In Human Clear Cell Renal Cell Carcinoma

Actin-Binding and Cell Proliferation Activities of Angiomotin Family Members Are Regulated by Hippo Pathway-Mediated Phosphorylation

MP99-11 ANGIOMOTIN REGULATES PROSTATE CANCER CELL PROLIFERATION BY SIGNALING THROUGH HIPPO-YAP PATHWAY

MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells.

Angiomotin promotes renal epithelial and carcinoma cell proliferation by retaining the nuclear YAP.

Research progress of angiomotin and cancer

Induced expression of AMOT reverses adriamycin resistance in breast cancer cells

Knockdown of RAC1 and VASP gene expression inhibits breast cancer cell migration.

RHAMM inhibits cell migration via the AKT/GSK3β/Snail axis in luminal A subtype breast cancer.

Angiomotin-like 1 plays a tumor-promoting role in glioma by enhancing the activation of YAP1 signaling